The effects of an alpha blocking agent on the respiratory distress syndrome with disseminated intravascular coagulation in the newborn infants and experimental animals.
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D000818:Animals; D001777:Blood Coagulation / Q000187:drug effects; D004211:Disseminated Intravascular Coagulation / Q000188:drug therapy*; D005260:Female; D006330:Heart Defects, Congenital / Q000188:drug therapy; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000188:drug therapy; D008297:Male; D010643:Phenoxybenzamine / Q000627:therapeutic use*; D011817:Rabbits; D012127:Respiratory Distress Syndrome, Newborn / Q000188:drug therapy*; D012131:Respiratory Insufficiency / Q000188:drug therapy; D012593:Sclerema Neonatorum / Q000188:drug therapy
D000317:Adrenergic alpha-Antagonists; D010643:Phenoxybenzamine